Several previous studies reported that high expression of PRDX4 demonstrated an unfavorable prognosis in colorectal cancer [63], lung squamous cell carcinoma [64], oral cavity squamous cell carcinoma [65], and urinary bladder carcinoma [66]. Here, PRDX4 is linked to oral cavity squamous cell carcinoma.